Visiomics

Curated by Signal

Online platform for liquid biopsies based multiomics analysis for tumor diagnostics

Overview

VISIOMICS is an integrated bioinformatics platform for tumor diagnostics. The platform offers a visual representation of the image and multi-omics data obtained from the liquid biopsies. It enables tumor diagnostics by translating the data into diagnostic analysis workflows and also connects to a multidisciplinary expert consortium.

Key facts

Headquarters: Vienna, Austria
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Ares Genetics
Provider of DNA-based precision medicine for infectious diseases
Life Sciences TechnologyVienna, Austria
Dawn Bio
Developer of treatments for womens reproductive health
Life Sciences TechnologyWien, Austria
Norganoid
Developer of brain-on-chip solution for accelerating drug research
Life Sciences TechnologyGraz, Austria

About Visiomics

What does Visiomics do?

VISIOMICS is an integrated bioinformatics platform for tumor diagnostics.

Where is Visiomics headquartered?

Visiomics is headquartered in Vienna, Austria.

Which sector is Visiomics in?

Visiomics operates in Life Sciences Technology.

Who are Visiomics's competitors?

Companies similar to Visiomics include Ares Genetics, Dawn Bio, and Norganoid.